Malaria- The larger problem in Africa.

* No. of malaria cases
Source: WHO World Malaria Report 2024

BLISS GVS PHARMA IS A LEADING GLOBAL COMPANY DEDICATED TO DELIVERING PHARMACEUTICAL FORMULATIONS THAT SIGNIFICANTLY ENHANCE ACCESSIBILITY & ELEVATE THE QUALITY OF LIFE FOR INDIVIDUALS WORLDWIDE.

For decades, Africa has been struggling to combat malaria. BLISS GVS PHARMA has been at the forefront of efforts to reduce the malaria burden for over 20 years with its range of antimalarial products, including LONART, GSUNATE, GVITHER, and P-ALAXIN. Through the initiative "ACT FOR AFRICA," BLISS GVS PHARMA aims to empower doctors and other stakeholders by raising awareness and providing education on how to reduce the impact of malaria.

Our Manifesto

Africa.

ENGULFED BY THE THREAT OF MALARIA.
MALARIA, AN INCREASING BURDEN.
OF SUFFERING. OF LOSS.

Africa.

SURVIVING, DESPITE ALL FLAWS.

Africa.

STANDING STILL.
EVERY INCREASING NUMBER, A PAINFUL STING.
BUT, FOR HOW LONG?
THE WAIT HAS TO END.
AND THE END HAS TO BEGIN.

TODAY. HERE. TOGETHER.

THE HOPE OF A PROMISING TOMORROW, STRONGER.
RECOVERIES, FASTER.
HEALTH AND WELL-BEING FOR ALL, BETTER.
ALL ACHIEVABLE WITH AN ACT*.

An Act for defence.

An Act for difference.

An Act for tolerence.

Act. Now. Today. Together

UNDERSTAND MALARIA

World Malaria Day 2025